Skip to main content
77°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Celyad Sa ADR
(NQ:
CYAD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.2000 (10)
Ask (Size)
0.5770 (1)
Prev. Close
0.4700
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
22,593,956
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
September 07, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
September 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Performance
More News
Read More
Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
September 04, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
August 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology announces receipt of Nasdaq delisting notice
May 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 05, 2023
Via
Benzinga
Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq
May 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
May 05, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price
April 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 19, 2023
Via
Benzinga
Celyad Oncology announces receipt of Nasdaq notice
April 04, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology appoints Georges Rawadi as its new CEO
March 24, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology reports full year 2022 financial results and recent business highlights
March 23, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Earnings Scheduled For March 23, 2023
March 23, 2023
Via
Benzinga
Celyad Oncology to announce full year 2022 financial results and host conference call
March 17, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 15, 2023
Via
Benzinga
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 15, 2023
Via
Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
March 15, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 15, 2023
Via
InvestorPlace
Celyad Oncology announces non-cash impairment
March 15, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
REPEAT -- Celyad Oncology SA - Letter to Shareholders
March 01, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
Celyad Oncology SA - Letter to Shareholders
February 28, 2023
From
Celyad Oncology SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 23, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.